COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
FRIDAY, April 8, 2022 (HealthDay News) — COVID-19 is associated with an increased risk for deep vein thrombosis, pulmonary embolism, and bleeding, according to a study published online April 6 in The BMJ.Ioannis Katsoularis, M.D., from Umeå Universit…
Learn MoreIntra-Articular Injection of Triamcinolone Beneficial in Hip Osteoarthritis
FRIDAY, April 8, 2022 (HealthDay News) — For patients with hip osteoarthritis and at least moderate pain, an ultrasound-guided intra-articular hip injection of corticosteroid and local anesthetic, administered with advice and education, is effective …
Learn MoreACC: Lasting Reduction in BP Seen With Radiofrequency Renal Denervation
FRIDAY, April 8, 2022 (HealthDay News) — Radiofrequency renal denervation yields clinically meaningful and lasting blood pressure reductions up to 36 months, according to a study published online April 4 in The Lancet to coincide with the annual meeting of the American College of Cardiology, held from April 2 to 4 in Washington, D.C.
Felix Mahfoud, M.D., from Saarland University in Homburg, Germany, and colleagues conducted a randomized, single-blind, sham-controlled trial enrolling patients from 25 clinical centers with uncontrolled hypertension. Participants had 24-hour ambulatory systolic blood pressure between 140 mm Hg and
In the renal denervation group, the researchers observed significant reductions from baseline in mean ambulatory systolic and diastolic blood pressure, and these numbers were significantly lower than those in the sham control group at 24 and 36 months, despite a similar intensity of antihypertensive drug treatment. At 36 months, 77 and 93 percent of patients in the renal denervation and sham control groups, respectively, adhered to medication. The reduction in ambulatory systolic blood pressure at 36 months was −18.7 and −8.6 mm Hg for the renal denervation and sham control groups, respectively.
“Given this long-term safety and efficacy finding, renal denervation could provide an adjunctive treatment modality in the management of patients with hypertension,” the authors write.
Several authors disclosed financial ties to pharmaceutical and medical device companies, including Medtronic, which funded the study.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Learn MoreBenefits of Smoking Cessation Quantified in Patients With ASCVD
FRIDAY, April 8, 2022 (HealthDay News) — For patients with established atherosclerotic cardiovascular disease, the treatment benefit of smoking cessation is equivalent to the use of targeted pharmaceutical interventions in persistent smokers, accordi…
Learn MoreInsomnia Linked to Recurrent MACE in Coronary Heart Disease
FRIDAY, April 8, 2022 (HealthDay News) — For patients with coronary heart disease (CHD), insomnia is associated with an increased risk for recurrent major adverse cardiovascular events (MACE), according to a study presented at the annual congress of …
Learn MoreRecommendations Updated for Management of Heart Failure
FRIDAY, April 8, 2022 (HealthDay News) — In a clinical practice guideline issued by the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America and published online April 1 in the Journal of the Americ…
Learn MoreAmerican Academy of Dermatology, March 25 to 29
The annual meeting of the American Academy of Dermatology was held from March 25 to 29 in Boston and attracted more than 12,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested…
Learn MoreVaccination Mandate for Federal Workers Reinstated by Appeals Court
FRIDAY, April 8, 2022 (HealthDay News) — A rule requiring U.S. federal government employees to be vaccinated against COVID-19 has been reinstated by a federal appeals court.The mandate was introduced in September but enforcement was halted in January…
Learn MoreAHA News: 12-Year-Old’s Stroke Revealed an Undiagnosed Congenital Condition
FRIDAY, April 8, 2022 (American Heart Association News) — Ten days before his 13th birthday, Trenden Johnston spent the afternoon doing yardwork and bouncing on a trampoline. So when his mom left to pick up dinner, he went to his room to rest.Suddenl…
Learn MoreU.S. Life Expectancy Drops for 2nd Year in a Row
THURSDAY, April 7, 2022 (HealthDay News) – Researchers report that life expectancy in the United States dropped in 2021, continuing a troubling trend that began in the first year of the pandemic.Specifically, average U.S. life expectancy tumbled from …
Learn More